300 related articles for article (PubMed ID: 25137428)
1. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
Neely EK; Kumar RB; Payne SL; Ranadive SA; Suchet DI
J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
[TBL] [Abstract][Full Text] [Related]
2. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.
Mauras N; Gonzalez de Pijem L; Hsiang HY; Desrosiers P; Rapaport R; Schwartz ID; Klein KO; Singh RJ; Miyamoto A; Bishop K
J Clin Endocrinol Metab; 2008 Mar; 93(3):823-31. PubMed ID: 18165285
[TBL] [Abstract][Full Text] [Related]
3. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review.
Shams K; Cameo T; Fennoy I; Hassoun AA; Lerner SE; Aranoff GS; Sopher AB; Yang C; McMahon DJ; Oberfield SE
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):725-30. PubMed ID: 24756052
[TBL] [Abstract][Full Text] [Related]
4. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
Hero M; Wickman S; Dunkel L
Clin Endocrinol (Oxf); 2006 May; 64(5):510-3. PubMed ID: 16649968
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
Salehpour S; Alipour P; Razzaghy-Azar M; Ardeshirpour L; Shamshiri A; Monfared MF; Gharib A
Horm Res Paediatr; 2010; 74(6):428-35. PubMed ID: 20628237
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
Hero M; Norjavaara E; Dunkel L
J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
[TBL] [Abstract][Full Text] [Related]
7. Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome.
Wikström AM; Bay K; Hero M; Andersson AM; Dunkel L
J Clin Endocrinol Metab; 2006 Nov; 91(11):4705-8. PubMed ID: 16926256
[TBL] [Abstract][Full Text] [Related]
8. Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature.
Mauras N; Ross JL; Gagliardi P; Yu YM; Hossain J; Permuy J; Damaso L; Merinbaum D; Singh RJ; Gaete X; Mericq V
J Clin Endocrinol Metab; 2016 Dec; 101(12):4984-4993. PubMed ID: 27710241
[TBL] [Abstract][Full Text] [Related]
9. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
Lanes R; Gunczler P
Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
[TBL] [Abstract][Full Text] [Related]
10. Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study.
Papadimitriou DT; Dermitzaki E; Papagianni M; Papaioannou G; Papaevangelou V; Papadimitriou A
J Endocrinol Invest; 2016 Apr; 39(4):439-46. PubMed ID: 26507391
[TBL] [Abstract][Full Text] [Related]
11. Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature.
Hero M; Mäkitie O; Kröger H; Nousiainen E; Toiviainen-Salo S; Dunkel L
Horm Res; 2009; 71(5):290-7. PubMed ID: 19339794
[TBL] [Abstract][Full Text] [Related]
12. Novel treatment of short stature with aromatase inhibitors.
Dunkel L; Wickman S
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):345-56. PubMed ID: 14623531
[TBL] [Abstract][Full Text] [Related]
13. [Clinical efficacy of letrozole in boys with idiopathic central precocious puberty].
Zhao X; Zhang Q
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):397-400. PubMed ID: 24750838
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment with GH and anastrozole in a pubertal boy with Cushing's disease and postsurgical GH deficiency.
Boronat M; Marrero D; López-Plasencia Y; Nóvoa Y; García-Delgado Y; Nóvoa FJ
Eur J Endocrinol; 2012 Jun; 166(6):1101-5. PubMed ID: 22447814
[TBL] [Abstract][Full Text] [Related]
15. Are aromatase inhibitors in boys with predicted short stature and/or rapidly advancing bone age effective and safe?
Ferris JA; Geffner ME
J Pediatr Endocrinol Metab; 2017 Mar; 30(3):311-317. PubMed ID: 28207416
[TBL] [Abstract][Full Text] [Related]
16. Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B.
Hero M; Tommiska J; Vaaralahti K; Laitinen EM; Sipilä I; Puhakka L; Dunkel L; Raivio T
Fertil Steril; 2012 May; 97(5):1242-7. PubMed ID: 22405597
[TBL] [Abstract][Full Text] [Related]
17. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial.
Wickman S; Sipilä I; Ankarberg-Lindgren C; Norjavaara E; Dunkel L
Lancet; 2001 Jun; 357(9270):1743-8. PubMed ID: 11403810
[TBL] [Abstract][Full Text] [Related]
18. Marked increase of final height by long-term aromatase inhibition in a boy with idiopathic short stature.
Krebs A; Moske-Eick O; Doerfer J; Roemer-Pergher C; van der Werf-Grohmann N; Schwab KO
J Pediatr Endocrinol Metab; 2012; 25(5-6):581-5. PubMed ID: 22876562
[TBL] [Abstract][Full Text] [Related]
19. Letrozole significantly improves growth potential in a pubertal boy with growth hormone deficiency.
Zhou P; Shah B; Prasad K; David R
Pediatrics; 2005 Feb; 115(2):e245-8. PubMed ID: 15653791
[TBL] [Abstract][Full Text] [Related]
20. Update on the role of aromatase inhibitors in growth disorders.
Dunkel L
Horm Res; 2009 Jan; 71 Suppl 1():57-63. PubMed ID: 19153508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
